These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15781660)

  • 1. Mimicry of a cellular low energy status blocks tumor cell anabolism and suppresses the malignant phenotype.
    Swinnen JV; Beckers A; Brusselmans K; Organe S; Segers J; Timmermans L; Vanderhoydonc F; Deboel L; Derua R; Waelkens E; De Schrijver E; Van de Sande T; Noël A; Foufelle F; Verhoeven G
    Cancer Res; 2005 Mar; 65(6):2441-8. PubMed ID: 15781660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-aminoimidazole-4-carboxamide riboside enhances effect of ionizing radiation in PC3 prostate cancer cells.
    Isebaert SF; Swinnen JV; McBride WH; Begg AC; Haustermans KM
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1515-23. PubMed ID: 21944462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate enhances the antianabolic and antiproliferative effects of 5-aminoimidazole-4-carboxamide riboside.
    Beckers A; Organe S; Timmermans L; Vanderhoydonc F; Deboel L; Derua R; Waelkens E; Brusselmans K; Verhoeven G; Swinnen JV
    Mol Cancer Ther; 2006 Sep; 5(9):2211-7. PubMed ID: 16985054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Amino-4-imidazolecarboxamide riboside potentiates the metabolism and anti-human immunodeficiency virus activity of 2',3'-dideoxyinosine.
    Gong YF; Srinivas RV; Fridland A
    Mol Pharmacol; 1993 Jul; 44(1):30-6. PubMed ID: 8341276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A HPLC method for simultaneous determination of 5-aminoimidazole-4-carboxamide riboside and its active metabolite 5-aminoimidazole-4-carboxamide ribotide in tumor-bearing nude mice plasma and its application to pharmacokinetics study.
    Cheng X; Guo L; Li Z; Li L; Zhou T; Lu W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Feb; 915-916():64-70. PubMed ID: 23340307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 5-amino-4-imidazolecarboxamide riboside (AICA-riboside) on the purine nucleotide synthesis and growth of rat kidney cells in culture: study with [15N]aspartate.
    Nissim I; Yudkoff M; Nissim I; States B
    J Cell Physiol; 1989 Mar; 138(3):536-40. PubMed ID: 2925797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AICA-riboside (acadesine), an activator of AMP-activated protein kinase with potential for application in hematologic malignancies.
    Van Den Neste E; Van den Berghe G; Bontemps F
    Expert Opin Investig Drugs; 2010 Apr; 19(4):571-8. PubMed ID: 20367195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-arterial AICA-riboside administration induces NO-dependent vasodilation in vivo in human skeletal muscle.
    Bosselaar M; Boon H; van Loon LJ; van den Broek PH; Smits P; Tack CJ
    Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E759-66. PubMed ID: 19602584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5'-aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells.
    Garcia-Gil M; Pesi R; Perna S; Allegrini S; Giannecchini M; Camici M; Tozzi MG
    Neuroscience; 2003; 117(4):811-20. PubMed ID: 12654334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AICA riboside both activates AMP-activated protein kinase and competes with adenosine for the nucleoside transporter in the CA1 region of the rat hippocampus.
    Gadalla AE; Pearson T; Currie AJ; Dale N; Hawley SA; Sheehan M; Hirst W; Michel AD; Randall A; Hardie DG; Frenguelli BG
    J Neurochem; 2004 Mar; 88(5):1272-82. PubMed ID: 15009683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate and 5-aminoimidazole-4-carboxamide riboside exert synergistic anticancer action against human breast cancer and hepatocellular carcinoma.
    Cheng XL; Zhou TY; Li B; Li MY; Li L; Li ZQ; Lu W
    Acta Pharmacol Sin; 2013 Jul; 34(7):951-9. PubMed ID: 23603981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 and acetyl-CoA carboxylase: the metabolic syndrome of breast cancer.
    Brunet J; Vazquez-Martin A; Colomer R; Graña-Suarez B; Martin-Castillo B; Menendez JA
    Mol Carcinog; 2008 Feb; 47(2):157-63. PubMed ID: 17620310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy.
    Pan Q; Bao LW; Kleer CG; Sabel MS; Griffith KA; Teknos TN; Merajver SD
    Cancer Res; 2005 Sep; 65(18):8366-71. PubMed ID: 16166314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).
    Zhuge J
    Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5 '-Amino-4-imidazolecarboxamide riboside induces apoptosis in human neuroblastoma cells via the mitochondrial pathway.
    Garcia-Gil M; Bertini F; Pesi R; Voccoli V; Tozzi MG; Camici M
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1265-70. PubMed ID: 17065104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo.
    Xia Q; Sung J; Chowdhury W; Chen CL; Höti N; Shabbeer S; Carducci M; Rodriguez R
    Cancer Res; 2006 Jul; 66(14):7237-44. PubMed ID: 16849572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMPK or ZMPK?
    Shakulov RS
    Med Hypotheses; 2006; 67(3):670. PubMed ID: 16762515
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of mast cell mediator release by 5-amino-4-imidazolecarboxamide riboside.
    Marquardt DL; Gruber HE
    Biochem Pharmacol; 1986 Dec; 35(24):4415-21. PubMed ID: 2947580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes.
    Vincent MF; Marangos PJ; Gruber HE; Van den Berghe G
    Diabetes; 1991 Oct; 40(10):1259-66. PubMed ID: 1657665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ErbB-4 may control behavior of prostate cancer cells and serve as a target for molecular therapy.
    Ben-Yosef R; Starr A; Karaush V; Loew V; Lev-Ari S; Barnea I; Lidawi G; Shtabsky A; Greif Y; Yarden Y; Vexler A
    Prostate; 2007 Jun; 67(8):871-80. PubMed ID: 17440944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.